期刊文献+
共找到11篇文章
< 1 >
每页显示 20 50 100
遗传性多发性骨软骨瘤的治疗探讨 被引量:2
1
作者 李康华 陈雷 +1 位作者 卢邦宝 胡朝晖 《医学临床研究》 CAS 2007年第1期57-58,共2页
【目的】探讨遗传性多发性骨软骨瘤的手术时机。【方法】回顾分析随访23例经临床、X线平片检查诊断为遗传性多发性骨软骨瘤的复发、并发症发生与手术时机的情况。【结果】早期手术病人复发率低,并发症发生率低;延期手术病人并发症发生情... 【目的】探讨遗传性多发性骨软骨瘤的手术时机。【方法】回顾分析随访23例经临床、X线平片检查诊断为遗传性多发性骨软骨瘤的复发、并发症发生与手术时机的情况。【结果】早期手术病人复发率低,并发症发生率低;延期手术病人并发症发生情况:恶变发生于胫骨1例、股骨1例,假性Madelung畸形1例,血管并发症:假性动脉瘤1例,小腿恶变截肢1例。【结论】延期手术病人手术复杂、创伤大,遗传性多发性骨软骨瘤应发现后早期进行手术治疗。 展开更多
关键词 外生骨疣 多发性遗传性/治疗
下载PDF
脾切除治疗遗传性球形红细胞增多症17例 被引量:2
2
作者 李磊 贾新建 《陕西医学杂志》 CAS 2010年第10期1392-1393,共2页
关键词 椭圆形红细胞增多症 遗传性/治疗 脾大/外科学 @脾切除
下载PDF
LHON患者基因治疗后视功能恢复与视神经纤维层厚度关联分析 被引量:1
3
作者 元佳佳 张勇 +4 位作者 陈长征 杨雪莹 缪青梅 Kai Yoon Fan 李斌 《中华实验眼科杂志》 CAS CSCD 北大核心 2022年第10期908-913,共6页
目的探讨Leber遗传性视神经病变(LHON)患者接受基因治疗后视功能恢复与视网膜神经纤维层(RNFL)厚度变化之间的关联。方法采用多中心非随机单臂临床试验设计,于2017年12月至2018年12月在华中科技大学同济医学院附属同济医院、十堰市太和... 目的探讨Leber遗传性视神经病变(LHON)患者接受基因治疗后视功能恢复与视网膜神经纤维层(RNFL)厚度变化之间的关联。方法采用多中心非随机单臂临床试验设计,于2017年12月至2018年12月在华中科技大学同济医学院附属同济医院、十堰市太和医院及武汉大学附属鄂州市中心医院纳入LHON患者159例,所有患眼均接受重组腺相关病毒2-还原型辅酶Ⅰ脱氢酶4(rAAV2-ND4)0.05μl玻璃体腔注射,于术前及术后1、3、6、12个月进行随访;采用标准对数视力表检查患眼最佳矫正视力(BCVA)(转换为LogMAR视力);采用Humphrey自动视野计测定患眼视野指数(VFI)和平均偏差(MD);采用Spectralis?HRA+OCT仪测量患眼视盘上方、下方、颞侧、鼻侧和平均RNFL厚度。以术后第12个月BCVA、视野和RNFL厚度作为治疗的主要结局。依据治疗后12个月BCVA改善情况将患者分为注射眼视力改善组81眼、注射眼视力未改善组62眼、未注射眼视力改善组65眼和未注射眼视力未改善组78眼;依据术后第12个月VFI改善情况将患者分为注射眼VFI改善组48眼、注射眼VFI未改善组71眼、未注射眼VFI改善组47眼和未注射眼VFI未改善组72眼,依据MD改善情况分为注射眼MD改善组52眼、注射眼MD未改善组67眼、未注射眼MD改善组47眼和未注射眼MD未改善组72眼。采用Pearson线性回归法分析各组患眼BCVA、VFI和MD恢复情况与RNFL厚度之间的关联。结果治疗后12个月,注射眼和未注射眼BCVA(LogMAR视力)分别为1.37±0.55和1.29±0.59,分别优于注射前的1.70±0.41和1.53±0.51,差异均有统计学意义(t=4.920、3.550,均P<0.001)。治疗后12个月注射眼VFI较治疗前明显改善,MD明显下降,差异均有统计学意义(均P<0.001);未注射眼VFI较治疗前明显提高,MD有所下降,差异均有统计学意义(均P<0.01)。治疗后RNFL厚度总体逐渐变薄。注射眼视力提高组BCVA与视网膜上方、下方、鼻侧、平均RNFL厚度均呈负相关(r=-0.362、-0.292、-0.307、-0.308,均P<0.05)。注射眼VFI提高组VFI与上方、下方、鼻侧、平均RNFL厚度均呈正相关(r=0.439、0.356、0.294、0.401,均P<0.05)。注射眼MD提高组MD与上方、下方、鼻侧、平均RNFL厚度均呈正相关(r=0.495、0.424、0.377、0.474,均P<0.05)。结论LHON患者基因治疗后RNFL厚度与视功能恢复程度有明显关联,RNFL较厚眼视功能恢复较好。 展开更多
关键词 基因疗法 Leber遗传性视神经病变/治疗 视力 视野 视神经纤维层厚度 光相干断层扫描 重组腺相关病毒 还原型辅酶Ⅰ脱氢酶4
下载PDF
Identification of Lynch syndrome: How should we proceed in the 21^(st) century? 被引量:3
4
作者 Antoni Castells Francesc Balaguer +2 位作者 Sergi Castellví-Bel Victòria Gonzalo Teresa Ocaa 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第33期4413-4416,共4页
Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common form of hereditary colorectal cancer. Although great advances in the understanding of its molecular basis have taken... Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common form of hereditary colorectal cancer. Although great advances in the understanding of its molecular basis have taken place in the last decade, optimal selection of individuals for HNPCC genetic testing remains controversial. This is especially relevant since colonoscopy has been proven effective for reducing colorectal cancer incidence and mortality in individuals at-risk for this disorder. In this manuscript, we summarize the most significant contributions to this important issue that have appearedin the last few years. 展开更多
关键词 Hereditary non-polyposis colorectal cancer SCREENING PREVENTION Microsatellite instability GENETICS
下载PDF
Role of calcium in polycystic kidney disease:From signaling to pathology 被引量:5
5
作者 Alessandra Mangolini Lucia de Stephanis Gianluca Aguiari 《World Journal of Nephrology》 2016年第1期76-83,共8页
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited monogenic kidney disease. Characterized by the development and growth of cysts that cause progressive kidney enlargement, it ultimate... Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited monogenic kidney disease. Characterized by the development and growth of cysts that cause progressive kidney enlargement, it ultimately leads to end-stage renal disease. Approximately 85% of ADPKD cases are caused by mutations in the PKD1 gene, while mutations in the PKD2 gene account for the remaining 15% of cases. The PKD1 gene encodes for polycystin-1 (PC1), a large multi-functional memb-rane receptor protein able to regulate ion channel complexes, whereas polycystin-2 (PC2), encoded by the PKD2 gene, is an integral membrane protein that functions as a calcium-permeable cation channel, located mainly in the endoplasmic reticulum (ER). In the primary cilia of the epithelial cells, PC1 interacts with PC2 to form a polycystin complex that acts as a mechanosensor, regulating signaling pathways involved in the differentiation of kidney tubular epithelial cells. Despite progress in understanding the function of these proteins, the molecular mechanisms associated with the pathogenesis of ADPKD remain unclear. In this review we discuss how an imbalance between functional PC1 and PC2 proteins may disrupt calcium channel activities in the cilium, plasma membrane and ER, thereby altering intracellular calcium signaling and leading to the aberrant cell proliferation and apoptosis associated with the development and growth of renal cysts. Research in this feld could lead to the discovery of new molecules able to rebalance intracellular calcium, thereby normalizing cell proliferation and reducing kidney cyst progression. 展开更多
关键词 Autosomal dominant polycystic kidney disease Calcium signaling CAMP Cell growth Non-capacitative calcium entry
下载PDF
Current management of autosomal dominant polycystic kidney disease 被引量:7
6
作者 Jacob A Akoh 《World Journal of Nephrology》 2015年第4期468-479,共12页
Autosomal dominant polycystic kidney disease (ADPKD), the most frequent cause of genetic renal disease affecting approximately 4 to 7 million individuals worldwide and accounting for 7%-15% of patients on renal repl... Autosomal dominant polycystic kidney disease (ADPKD), the most frequent cause of genetic renal disease affecting approximately 4 to 7 million individuals worldwide and accounting for 7%-15% of patients on renal replacement therapy, is a systemic disorder mainly involving the kidney but cysts can also occur in other organs such as the liver, pancreas, arachnoid membrane and seminal vesicles. Though computed tomography and magnetic resonance imaging (MRI) were similar in evaluating 81% of cystic lesions of the kidney, MRI may depict septa, wall thickening or enhancement leading to upgrade in cyst classification that can affect management. A screening strategy for intracranial aneurysms would provide 1.0 additional year of life without neurological disability to a 20-year-old patient with ADPKD and reduce the fnancial impact on society of the disease. Current treatment strategies include reducing: cyclic adenosine monophosphate levels, cell proliferation and fluid secretion. Several randomised clinical trials (RCT) including mammalian target of rapamycin inhibitors, somatostatin analoguesand a vasopressin V2 receptor antagonist have beenperformed to study the effect of diverse drugs ongrowth of renal and hepatic cysts, and on deteriorationof renal function. Prophylactic native nephrectomy isindicated in patients with a history of cyst infection orecurrent haemorrhage or to those in whom space musbe made to implant the graft. The absence of largeRCT on various aspects of the disease and its treatmen leaves considerable uncertainty and ambiguity in many aspects of ADPKD patient care as it relates to end stage renal disease (ESRD). The outlook of patients with ADPKD is improving and is in fact much better than that for patients in ESRD due to other causes. This review highlights the need for well-structured RCTs as a frst step towards trying newer interventions so as to develop updated clinical management guidelines. 展开更多
关键词 Autosomal dominant polycystic kidney disease Native nephrectomy Cyst decortication Kidney transplantation HYPERTENSION Drug therapy End stage renal disease Extrarenal manifestatation Total kidney volume
下载PDF
Fresh Frozen Plasma for the Treatment of a Chinese Patient with Hereditary Angioedema 被引量:2
7
作者 Rui Tang Hong-yu Zhang Jia Gan 《Chinese Medical Sciences Journal》 CAS CSCD 2009年第4期246-247,共2页
HEREDITARY angioedema (HAE) is an autosomal dominant inherited condition which was initially described by Osier in 1888.1 Patients with HAE can develop rapid subcutaneous or submucosal edema involving the hands, fee... HEREDITARY angioedema (HAE) is an autosomal dominant inherited condition which was initially described by Osier in 1888.1 Patients with HAE can develop rapid subcutaneous or submucosal edema involving the hands, feet, limbs, face, intestinal tract, even larynx and trachea. The mortality of an acute attack of HAE without treatment was reported as high as 30%.2 HAE is caused by the deficiency of Cl esterase inhibitor (CIINH) which results in episodes of edema in parts of the human body, 展开更多
关键词 fresh frozen plasma hereditary angioedema TREATMENT
下载PDF
Effect of Therapeutic Ginger on Genotoxic of Taxol Drug (Anti-Cancer) in Bone Marrow Cell of Male Mice
8
作者 Mona Mohammed Zaid AL-Sharif 《Journal of Life Sciences》 2011年第11期897-905,共9页
Medicinal use of spices/herbs has been gradually increased in the developed countries, Zingiber officinale (Ginger) is known to possess potent antioxidant and anti inflammatory properties. Therefore, the aim of this... Medicinal use of spices/herbs has been gradually increased in the developed countries, Zingiber officinale (Ginger) is known to possess potent antioxidant and anti inflammatory properties. Therefore, the aim of this study is to determine the possible anti-mutagenic effect of ginger against the genotoxic effect of anti-cancer drug Taxol 0.6 mg/kg. This study is conducted by using two types of cytogenetic studies in bone marrow cell of mal albino mice Mus musculus (average weight 25-30 g). The animals were randomly distributed into six groups, each of 14 mi[ce, (GI) was given the solvent, (G2) treatment of the medical dose of Taxol drug, (G3) treatment of ginger, (G4) a pre-treatment of ginger prior to treatment of drug, (G5) a simultaneous treatment of ginger and treatment of drug, (G6) a post-treatment of ginger after treatment drug. The study results show that significant increase in total chromosomal aberrations and significant increase in the number of micronuclei were observed after treatment drug. The significant structural aberrations were in the form of end-to-end associations. The numerical chromosomal aberrations were endomitosis and polyploid. The results showed that the frequencies of chromosomal aberrations and micronuclei in ginger treated group were not significantly different from control. Simultaneous treatment of ginger was found to be effective in reducing the genotoxic effects induced by drug Taxol especially in the total number of the chromosomal aberrations and the number of micronuclei. 展开更多
关键词 CYTOGENETIC GENOTOXIC TAXOL GINGER bone marrow mice chromosomal aberrations micronuclei
下载PDF
New SLC12A3 disease causative mutation of Gitelman's syndrome
9
作者 Teresa Grillone Miranda Menniti +6 位作者 Francesco Bombardiere Marco Flavio Michele Vismara Stefania Belviso Fernanda Fabiani Nicola Perrotti Rodolfo Iuliano Emma Colao 《World Journal of Nephrology》 2016年第6期551-555,共5页
Gitelman's syndrome(GS) is a salt-losing tubulopathy with an autosomal recessive inheritance caused by mutations of SLC12A3, which encodes for the thiazidesensitive Na Cl cotransporter. In this study we report a n... Gitelman's syndrome(GS) is a salt-losing tubulopathy with an autosomal recessive inheritance caused by mutations of SLC12A3, which encodes for the thiazidesensitive Na Cl cotransporter. In this study we report a new mutation of SLC12A3 found in two brothers affected by GS. Hypokalemia, hypocalciuria and hyperreninemia were present in both patients while hypomagnesemia was detected only in one. Both patients are compound heterozygotes carrying one well known GS associated mutation(c.2581 C > T) and a new one(c.283 del C) in SLC12A3 gene. The new mutation results in a possible frame-shift with a premature stopcodon(pG ln95 Argfs X19). The parents of the patients, heterozygous carriers of the mutations found in SLC12A3, have no disease associated phenotype. Therefore, the new mutation is causative of GS. 展开更多
关键词 Gitelman’s syndrome Thiazide-sensitive NaCl cotransporter Frame-shift mutation TUBULOPATHY SLC12A3 gene
下载PDF
Physical activity and exercise training in young people with cystic fibrosis:Current recommendations and evidence
10
作者 Craig A. Williams Daniel Stevens 《Journal of Sport and Health Science》 SCIE 2013年第1期39-46,共8页
Despite the acceptance of physical activity (PA) being integral to a young person's health, children with disability often exhibit low levels of PA. In young people with cystic fibrosis (CF) the importance of exe... Despite the acceptance of physical activity (PA) being integral to a young person's health, children with disability often exhibit low levels of PA. In young people with cystic fibrosis (CF) the importance of exercise and daily PA is acknowledged by clinicians and their support teams, however, there is a lack of knowledge related to its prescription. CF is a recessive genetic disorder affecting the lung, pancreas and sweat glands. CF is the most common life shortening genetic disease in the Caucasian population for which there is no cure. In the UK, CF affects over 9000 people, with 4000 under 16 years of age. Only about half of the CF population can expect to live beyond 40 years of age. Besides drug therapies, rehabilitative exercise programmes form an important component of treatment and long term exercise programmes are considered positive treatment strategies, but all lack any detailed prescriptive information. Several reviews and editorials have highlighted the lack of evidence based research in PA and exercise training in young people with CF; but advocate a greater need for understanding the role of exercise in therapeutic interventions. The purpose of this review is to update the reader on the current recommendations and evidence in PA and exercise training for young people with CE These developments have extended our understanding of PA and exercise training in children and adolescents with CF, and its implementation in the management of this chronic disease. 展开更多
关键词 Cystic fibrosis Exercise training PAEDIATRICS Physical activity Young people
下载PDF
光动力疗法治疗卵黄样黄斑营养不良并发脉络膜新生血管临床观察 被引量:1
11
作者 郑红梅 邢怡桥 +4 位作者 陈长征 宋艳萍 陈中山 李璐 郁想想 《中华眼底病杂志》 CAS CSCD 北大核心 2011年第6期538-541,共4页
目的观察光动力疗法(PDT)治疗卵黄样黄斑营养不良(VMD)并发脉络膜新生血管(CNV)的临床疗效。方法回顾性分析行PDT治疗的7例VMD并发CNV患者7只眼的临床资料。患者中男性4例,女性3例。年龄20~54岁。治疗前后行最佳矫正视力(BCVA... 目的观察光动力疗法(PDT)治疗卵黄样黄斑营养不良(VMD)并发脉络膜新生血管(CNV)的临床疗效。方法回顾性分析行PDT治疗的7例VMD并发CNV患者7只眼的临床资料。患者中男性4例,女性3例。年龄20~54岁。治疗前后行最佳矫正视力(BCVA)、裂隙灯显微镜、眼底彩色照相、荧光素眼底血管造影(FFA)、吲哚青绿血管造影(ICGA)、频域光相干断层扫描(SI〉OCT)以及眼电图(EOG)、视网膜电图(ERG)等检查。患眼BCVA数指/眼前~0.6;光感受器内外节(IS/OS)界面下积液,视网膜水肿,平均中央视网膜厚度(506.00±30.71)μm。PDT治疗按照标准常规操作完成。治疗后随访2~11个月,平均随访时间6.3个月。观察BCVA及CNV变化以及与治疗相关的副作用。结果末次随访时,患眼BCVA0.12~1.0,均有不同程度提高;FFA及ICGA检查显示,CNV萎缩变小,渗漏减轻;SD-OCT检查见神经视网膜水肿减轻或消退,平均中央视网膜厚度下降为(401.00±52.22)μm,IS/OS界面与视网膜色素上皮间光反射暗区消失,黄斑恢复基本正常形态;未见与治疗相关的局部及全身副作用发生。结论PDT能有效治疗VMD并发的CNV,稳定或提高患者视力。 展开更多
关键词 脉络膜新生血管化/治疗 光化学疗法 黄斑变性/并发症 角膜营养不良 遗传性/治疗
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部